Aethlon Medical Inc EV/EBIT
Quel est le EV/EBIT de Aethlon Medical Inc?
Le EV/EBIT de Aethlon Medical Inc est N/A
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Industrials secteur sur NASDAQ par rapport à Aethlon Medical Inc
Que fait Aethlon Medical Inc?
the aethlon medical (nasdaq:aemd) mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. our aethlon adapt™ platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. the aethlon adapt™ product pipeline includes the hemopurifier®, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as hiv and hepatitis c.
Entreprises avec ev/ebit similaire à Aethlon Medical Inc
- Central African Gold a EV/EBIT de N/A
- AmWolf Capital a EV/EBIT de N/A
- Societa Editoriale Il Fatto S.p.A a EV/EBIT de N/A
- Aspira Women's Health a EV/EBIT de N/A
- Eurolife Brands a EV/EBIT de N/A
- The Alkaline Water a EV/EBIT de N/A
- Aethlon Medical Inc a EV/EBIT de N/A
- Polo Resources a EV/EBIT de N/A
- Taysha Gene Therapies a EV/EBIT de N/A
- Universal Ibogaine a EV/EBIT de N/A
- Powerlong Coml Mgmt Hldg Ltd a EV/EBIT de N/A
- Purple Innovation Inc a EV/EBIT de N/A
- Oncopeptides AB (publ) a EV/EBIT de N/A